Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. (October 2014) - Tuxen, Malgorzata K.; Cold, Soeren; Tange, Ulla B.; Balslev, Eva; Nielsen, Dorte L.